JP2002306432A - 組織灌流を評価する方法及び装置 - Google Patents
組織灌流を評価する方法及び装置Info
- Publication number
- JP2002306432A JP2002306432A JP2001399031A JP2001399031A JP2002306432A JP 2002306432 A JP2002306432 A JP 2002306432A JP 2001399031 A JP2001399031 A JP 2001399031A JP 2001399031 A JP2001399031 A JP 2001399031A JP 2002306432 A JP2002306432 A JP 2002306432A
- Authority
- JP
- Japan
- Prior art keywords
- patient
- sensor
- measurement
- probe
- carbon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000010412 perfusion Effects 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims abstract description 54
- 239000000523 sample Substances 0.000 claims abstract description 67
- 238000001139 pH measurement Methods 0.000 claims abstract description 47
- 210000001519 tissue Anatomy 0.000 claims abstract description 35
- 238000005259 measurement Methods 0.000 claims abstract description 23
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 16
- 230000004044 response Effects 0.000 claims abstract description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 132
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 65
- 239000001569 carbon dioxide Substances 0.000 claims description 61
- 210000004400 mucous membrane Anatomy 0.000 claims description 45
- 238000009530 blood pressure measurement Methods 0.000 claims description 35
- 230000006378 damage Effects 0.000 claims description 34
- 208000027418 Wounds and injury Diseases 0.000 claims description 33
- 208000014674 injury Diseases 0.000 claims description 33
- 239000008280 blood Substances 0.000 claims description 32
- 210000004369 blood Anatomy 0.000 claims description 32
- 210000000214 mouth Anatomy 0.000 claims description 24
- 210000003296 saliva Anatomy 0.000 claims description 22
- 210000004379 membrane Anatomy 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 16
- 210000003437 trachea Anatomy 0.000 claims description 14
- 230000005669 field effect Effects 0.000 claims description 11
- 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 9
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 4
- 210000002200 mouth mucosa Anatomy 0.000 claims 11
- 230000002685 pulmonary effect Effects 0.000 claims 7
- 230000002708 enhancing effect Effects 0.000 claims 3
- 238000004868 gas analysis Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 210000004877 mucosa Anatomy 0.000 abstract description 6
- 230000000241 respiratory effect Effects 0.000 abstract 2
- 210000002345 respiratory system Anatomy 0.000 abstract 2
- 150000002500 ions Chemical class 0.000 description 32
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 239000011521 glass Substances 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- 230000009885 systemic effect Effects 0.000 description 9
- 208000028867 ischemia Diseases 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000002427 irreversible effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000001147 pulmonary artery Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000010444 Acidosis Diseases 0.000 description 3
- 230000007950 acidosis Effects 0.000 description 3
- 208000026545 acidosis disease Diseases 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000012212 insulator Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 206010040560 shock Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 102100040958 Aconitate hydratase, mitochondrial Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101000965314 Homo sapiens Aconitate hydratase, mitochondrial Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4238—Evaluating particular parts, e.g. particular organs stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/751,681 US20020087057A1 (en) | 2000-12-29 | 2000-12-29 | Method and apparatus for assessing tissue perfusion |
| US09/751681 | 2000-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002306432A true JP2002306432A (ja) | 2002-10-22 |
| JP2002306432A5 JP2002306432A5 (enExample) | 2005-08-04 |
Family
ID=25023032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001399031A Withdrawn JP2002306432A (ja) | 2000-12-29 | 2001-12-28 | 組織灌流を評価する方法及び装置 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020087057A1 (enExample) |
| EP (1) | EP1219234A1 (enExample) |
| JP (1) | JP2002306432A (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007195977A (ja) * | 2006-01-24 | 2007-08-09 | Zoll Medical Corp | 蘇生における再灌流保護 |
| JP2017502712A (ja) * | 2013-11-20 | 2017-01-26 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 外傷脳損傷ガイドラインシステム及び方法 |
| US11219737B2 (en) | 2006-01-24 | 2022-01-11 | Zoll Medical Corporation | Reperfusion protection in resuscitation |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219068D0 (en) * | 2002-08-16 | 2002-09-25 | Grampian Univ Hospitals | Apparatus and method |
| US7297113B1 (en) * | 2003-04-25 | 2007-11-20 | United States Of America As Represented By The Secretary Of The Navy | Microsensor system and method for measuring data |
| WO2005096920A1 (en) * | 2004-03-26 | 2005-10-20 | Healthcarelink | Apparatus and system for predictive health monitoring |
| US7291502B2 (en) * | 2006-03-15 | 2007-11-06 | Franco Wayne P | Method for performing a non-invasive blood gas test |
| US20080128265A1 (en) * | 2006-11-30 | 2008-06-05 | Imperial Innovations Limited | Electrode Assembly and System |
| US8425428B2 (en) | 2008-03-31 | 2013-04-23 | Covidien Lp | Nitric oxide measurements in patients using flowfeedback |
| US8652064B2 (en) * | 2008-09-30 | 2014-02-18 | Covidien Lp | Sampling circuit for measuring analytes |
| HU230008B1 (hu) * | 2009-09-01 | 2015-05-28 | Szegedi Tudományegyetem | Javított tonometriás eszköz a szervezet légzési elégtelenségének és regionális perfúzió-zavarának vizsgálatára |
| US8536626B2 (en) | 2011-04-28 | 2013-09-17 | Honeywell International Inc. | Electronic pH sensor die packaging |
| US20150374274A1 (en) * | 2014-06-30 | 2015-12-31 | Ace Jovanovski | Oral Detection Apparatus |
| DE102014019658B4 (de) * | 2014-12-19 | 2017-09-07 | Karl-Heinz Wenk | Sauerstoffsättigungsdetektionsvorrichtung zur Detektion und Signalisierung der arteriellen Sauerstoffsättigung und Verfahren zur Steigerung der körperlichen Leistungsfähigkeit |
| US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
| US12115001B2 (en) | 2019-10-15 | 2024-10-15 | Exostat Medical, Inc. | Tissue perfusion sensor and placement device |
| CA3154419A1 (en) * | 2019-10-15 | 2021-04-22 | Irvin T. Pierskalla | Carbon dioxide sensor |
| EP4322829A4 (en) * | 2021-04-14 | 2025-02-26 | Exostat Medical, Inc. | TISSUE PERFUSION SENSOR AND PLACEMENT DEVICE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4629424A (en) * | 1984-08-30 | 1986-12-16 | Integrated Ionics, Inc. | Intraoral ambient sensing device |
| US5456251A (en) * | 1988-08-26 | 1995-10-10 | Mountpelier Investments, S.A. | Remote sensing tonometric catheter apparatus and method |
| US5158083A (en) * | 1989-10-23 | 1992-10-27 | Mountpelier Investments, S.A. | Miniature pco2 probe for in vivo biomedical applications |
| US5341803A (en) * | 1993-06-22 | 1994-08-30 | Goldberg Michael S | Apparatus and method for monitoring gastric fluid pH |
| US6258046B1 (en) * | 1995-07-06 | 2001-07-10 | Institute Of Critical Care Medicine | Method and device for assessing perfusion failure in a patient by measurement of blood flow |
| US6055447A (en) * | 1995-07-06 | 2000-04-25 | Institute Of Critical Care Medicine | Patient CO2 Measurement |
| JPH10328212A (ja) * | 1997-06-02 | 1998-12-15 | Hideyuki Takeuchi | 歯科用プローブおよび歯科用診断装置 |
-
2000
- 2000-12-29 US US09/751,681 patent/US20020087057A1/en not_active Abandoned
-
2001
- 2001-12-17 EP EP01310531A patent/EP1219234A1/en not_active Withdrawn
- 2001-12-28 JP JP2001399031A patent/JP2002306432A/ja not_active Withdrawn
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007195977A (ja) * | 2006-01-24 | 2007-08-09 | Zoll Medical Corp | 蘇生における再灌流保護 |
| US9950134B2 (en) | 2006-01-24 | 2018-04-24 | Zoll Medical Corporation | Reperfusion protection in resuscitation |
| US11219737B2 (en) | 2006-01-24 | 2022-01-11 | Zoll Medical Corporation | Reperfusion protection in resuscitation |
| JP2017502712A (ja) * | 2013-11-20 | 2017-01-26 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 外傷脳損傷ガイドラインシステム及び方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1219234A1 (en) | 2002-07-03 |
| US20020087057A1 (en) | 2002-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002306432A (ja) | 組織灌流を評価する方法及び装置 | |
| Huttmann et al. | Techniques for the measurement and monitoring of carbon dioxide in the blood | |
| US6055447A (en) | Patient CO2 Measurement | |
| Washington et al. | Guidelines for exercise testing in the pediatric age group. From the Committee on Atherosclerosis and Hypertension in Children, Council on Cardiovascular Disease in the Young, the American Heart Association. | |
| Clark et al. | Noninvasive Assessment of Blood Gases1-3 | |
| US7618376B2 (en) | Device for assessing perfusion failure in a patient by measurement of blood flow | |
| US6216024B1 (en) | Method and device for assessing perfusion failure in a patient | |
| Heinonen et al. | Validation of air tonometric measurement of gastric regional concentrations of CO2 in critically ill septic patients | |
| US20010025151A1 (en) | Device for assessing perfusion failure in a patient by measurement of blood flow | |
| Aliwalas et al. | Agreement of carbon dioxide levels measured by arterial, transcutaneous and end tidal methods in preterm infants≤ 28 weeks gestation | |
| Uusaro et al. | Gastric mucosal end‐tidal P co2 difference as a continuous indicator of splanchnic perfusion | |
| Koch | Alveolar ventilation, diffusing capacity and the Aa Po2, difference in the newborn infant | |
| EP0643942A1 (en) | System and method of diagnosing bacterial growth | |
| USRE29703E (en) | Non-invasively measuring arterial oxygen tension | |
| Caples et al. | Respiratory monitoring tools in the intensive care unit | |
| Peabody et al. | Noninvasive monitoring of blood gases in the newborn | |
| Eberhard | Continuous oxygen monitoring of newborns by skin sensors | |
| Parker | Sensors for monitoring blood gases in intensive care | |
| Nahas et al. | Oxygen dissociation curve of arterial blood in men breathing high concentrations of oxygen | |
| Poets | Continuous monitoring techniques | |
| JP3547124B2 (ja) | 患者において灌流不全を評価するための方法およびデバイス | |
| Aufderhaar | Breath Analysis as Part of Pulmonary Function Diagnostics | |
| Lacerenza et al. | The role of cerebral oxygenation in pediatric lower respiratory tract infections based on insights from time domain near infrared spectroscopy tissue oximetry | |
| RU2363371C2 (ru) | Диагностический зонд и комплект для тонометрического исследования дыхательной недостаточности и недостаточности регионарного кровоснабжения организма | |
| Hess | Noninvasive respiratory monitoring during ventilatory support |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041228 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041228 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20060814 |